Eric Daniels
Corporate Officer/Principal bij KIORA PHARMACEUTICALS, INC.
Vermogen: 614 $ op 31-05-2024
Actieve functies van Eric Daniels
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21-10-2021 | - |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Directeur/Bestuurslid | - | - |
| Oprichter | - | - | |
| Bayon Therapeutics, Inc. | Directeur/Bestuurslid | - | - |
| Oprichter | - | - |
Loopbaan van Eric Daniels
Eerdere bekende functies van Eric Daniels
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Algemeen Directeur | - | - |
Opleiding van Eric Daniels
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
| Anderson School of Management | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Australië | 2 |
Operationeel
| Director/Board Member | 2 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
OccuRx Pty Ltd
OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Health Technology |
| Bayon Therapeutics, Inc. |
- Beurs
- Insiders
- Eric Daniels
- Ervaring
